Search

everythinglearnresearchcommunity

for

Search:↓

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Some alternative vitiligo treatments show promise, but none are as effective as psoralens and UVA.

Topical PUVA and tacrolimus ointment can effectively and safely treat infant alopecia universalis.

Topical alpha-terthienyl with UVA may safely treat psoriasis without cancer risk.

Phototherapy is effective and well-tolerated for treating childhood psoriasis and pityriasis lichenoides chronica.

UV treatment can damage hair, so protection is advised.

Various dermatologic treatments were effective for skin conditions like acne, rosacea, hair loss, and psoriasis from December 1986 to December 1987.

Many treatments for alopecia areata have inconsistent results; for under 10s, use minoxidil with a corticosteroid, and for over 10s, add ILC and consider diphenylcyclopropenone for widespread cases.

The document concluded that various dermatological treatments have different effectiveness and side effects, with some causing irritation, allergic reactions, or systemic effects.

Green tea may help with various skin conditions and protect the skin when taken orally or applied topically, but its effectiveness is not always proven.

Topical PUVA can cause temporary hair regrowth in some alopecia areata patients but doesn't change the long-term outcome.

Some people with severe hair loss saw hair regrowth after a specific light and drug treatment.

New treatments for vitiligo show promise but still face challenges, especially for hands and feet.

PUVA-turban therapy can help some people with severe alopecia areata regrow hair.

Superoxide dismutase (SOD) can prevent hair graying in mice.

Superoxide dismutase (SOD) can prevent hair graying in mice.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Dermatological treatments can have significant side effects, including allergic reactions, sexual dysfunction, and increased cancer risk.

The patient's symptoms improved with treatment but recurred when the steroid dose was reduced, requiring ongoing therapy.

Alopecia areata in children is often linked to genetics, autoimmune issues, and stress, and is treated with corticoids or PUVA therapy.

UVA1-light therapy successfully treated a child's skin condition, mycosis fungoides.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

PUVASOL might effectively treat complete scalp baldness.

Sunlight exposure improved a patient's skin condition, and there may be a link between a certain disease and skin growths; a leukemia treatment caused changes in hair color and growth.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Some medications might reverse gray hair, especially those that reduce inflammation or stimulate pigment production, and vitamin B might help.

A combination of oral cyclosporin and PUVA treatment worked well for a severe skin condition called generalized pustular psoriasis.

This therapy effectively treats resistant alopecia areata with minimal side effects.

The conference concluded that understanding hair and nail disorders is important, iron deficiency may be linked to hair loss, and while some treatments for skin conditions are effective, they may have risks and high costs.

Methotrexate effectively treated a 2-year-old's generalized pustular psoriasis without side effects.